Founder BRCA1/2 Mutations in the Europe: Implications for Hereditary Breast-Ovarian Cancer Prevention and Control

EPMA Journal - United Kingdom
doi 10.1007/s13167-010-0037-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Founder BRCA1/2 Mutations Among Male Patients With Breast Cancer in Israel

American Journal of Human Genetics
Genetics
1999English

BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2008English

Prevalence of the BRCA1 Founder Mutation C.5266dupin Brazilian Individuals At-Risk for the Hereditary Breast and Ovarian Cancer Syndrome

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Hereditary Breast Cancer: Mutations Within BRCA1 and BRCA2 With Phenotypic Responses

2000English

Frequency of BRCA1 Mutations in B&H Breast and Ovarian Cancer Patients

Genetics & Applications
2018English

Erratum: Corrigendum: BRCA1 Genomic Deletions Are Major Founder Mutations in Dutch Breast Cancer Patients

Nature Genetics
Genetics
1997English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Hereditary Breast and Ovarian Cancer Syndrome

Klinicka Onkologie
Oncology
2016English

Understanding Hereditary Breast and Ovarian Cancer

Clinical Journal of Oncology Nursing
Oncology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy